Search results
This Day In Sports: New name for the big building on Broadway
KTVB Boise· 5 hours agoAfter 44 seasons as Bronco Stadium, the facility that houses the famed blue turf becomes Albertsons...
Earnings call: Lonza maintains outlook despite Q1 performance lag By Investing.com
Investing.com· 7 days agoThe company confirmed its outlook for 2024, projecting flat constant exchange rate (CER) sales...
Cathie Wood Pulls the Trigger on These 2 ‘Strong Buy’ Stocks
TipRanks via Yahoo Finance· 15 hours agoFavoring high growth and disruptors, she often appears to be throwing caution to the wind and...
King of Country Music Drops Exciting News
Men's Journal· 19 hours agoAfter a long awaited five years, the King of Country Music's announcement has excited fans. Debuting his first release from his 31st album, George Strait...
What Does a Fox News Viewer See in One Day? You Have to See It to Believe.
Slate via Yahoo News· 3 days ago“If we don’t stop this, they can go after you. Every American’s at risk,” Scott continues, and it...
Q1 2024 Ocugen Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoMusunuri. Shankar Musunuri Thank you, Tiffany, and thank you all for joining us today. As detailed in our press release, we are excited to discuss the substantial progress of our game-changing ...
Novo Nordisk owner buys majority stake in Austrian life science tools company
AOL· 6 days agoNovo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, said on Wednesday it would buy a controlling stake of about 60% in Single Use Support, an Austria-based life ...
ACE will go where no one has gone before: Retail concessions at Lakeland Linder
The Ledger via Yahoo News· 19 hours agoHallstrand struck up a conversation with former airport directorGene Conrad, who left the city to...
PolygenRx Wants to Use Genetics to Guide Chronic Disease Treatments, Starting With Hypertension
GenomeWeb News· 3 hours agoGenetics, often typecast as the future of medicine for rare and monogenic conditions, could also be...
Earnings call: Aptose Biosciences targets AML treatment with tuspetinib By Investing.com
Investing.com· 6 days agoAptose Biosciences (NASDAQ:APTO) has focused its efforts on developing tuspetinib as part of a novel...
